Key result
Baseline 25-hydroxyvitamin D and parathyroid hormone levels were not associated with longitudinal progression of carotid arterial stiffness over a mean follow-up of 9.4 years (both P>0.1).
Why the study?
Do baseline 25-Hydroxyvitamin D and Parathyroid Hormone levels predict longitudinal changes in carotid arterial stiffness in a multi-ethnic cohort?
Cohort (n=2,580)
Do baseline 25-Hydroxyvitamin D and Parathyroid Hormone levels predict longitudinal changes in carotid arterial stiffness in a multi-ethnic cohort?
p-value: p=>0.1
Baseline levels of 25-hydroxyvitamin D and parathyroid hormone do not predict longitudinal progression of carotid arterial stiffness over nearly a decade.
Does not support baseline PTH or 25(OH)D for predicting carotid stiffness progression; leaves open their role in other vascular outcomes.
OBJECTIVE: To evaluate the impact of vitamin D and parathyroid hormone (PTH) on longitudinal changes in arterial stiffness. APPROACH AND RESULTS: Distensibility coefficient and Young's elastic modulus of the right common carotid artery were evaluated at baseline and after a mean (SD) of 9.4 (0.5) years in 2580 Multi-Ethnic Study of Atherosclerosis (MESA) participants. Cross-sectional and longitudinal associations were evaluated using multivariable linear regression and analysis of covariance. At baseline, participants were 60.1 (9.4) years old (54% female; 26% black, 20% Hispanic, 14% Chinese). Mean annualized 25(OH)D was <20 ng/dL in 816 participants, and PTH was >65 pg/dL in 285 participants. In cross-sectional analyses, low 25(OH)D (<20 ng/mL) was not associated with stiffer arteries after adjustment for cardiovascular disease risk factors (P>0.4). PTH >65 pg/mL was associated with stiffer arteries after adjustment for cardiovascular disease risk factors, other than systolic blood pressure (distensibility coefficient: β=-2.4×10(-4) mm Hg(-1), P=0.003; Young's elastic modulus: β=166 mm Hg, P=0.01); however, after adjustment for systolic blood pressure, these associations no longer were statistically significant. Longitudinal arterial stiffening was associated with older age (P<0.0001), higher systolic blood pressure (P<0.008), and use of antihypertensive medications (P<0.006), but not with 25(OH)D or PTH (both P>0.1). CONCLUSIONS: Carotid arterial stiffness is not associated with low 25(OH)D concentrations. Cross-sectional associations between arterial stiffness and high PTH were attenuated by systolic blood pressure. After nearly a decade of follow-up, neither baseline PTH nor 25(OH)D concentrations were associated with progression of carotid arterial stiffness.
No takes yet. Share an insight, caveat, or question.
Gepner et al. (2014) conducted a cohort in Arterial stiffness (n=2,580). 25-Hydroxyvitamin D and Parathyroid Hormone levels vs. Normal levels was evaluated on Longitudinal changes in carotid arterial stiffness (distensibility coefficient and Young's elastic modulus) (p=>0.1). Baseline 25-hydroxyvitamin D and parathyroid hormone levels were not associated with longitudinal progression of carotid arterial stiffness over a mean follow-up of 9.4 years (both P>0.1).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: